Marinus Pharmaceuticals reported 13.02M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 131.9M 19.38M
ALKERMES ALKS:US 217.86M 5.53M
Amgen AMGN:US $ 5084M 407M
Biogen BIIB:US $ 2105.1M 327.2M
Eisai 4523:JP Y 136858M 3305M
Esperion Therapeutics ESPR:US $ 9.66M 2.05M
Gilead Sciences GILD:US $ 4818M 348M
Intercept Pharmaceuticals ICPT:US $ 71.45M 16.38M
Intra Cellular Therapies ITCI:US $ 31.84M 8.71M
Marinus Pharmaceuticals MRNS:US 13.02M 11.5M
Neurocrine Biosciences NBIX:US $ 373.4M 67.4M
Ptc Therapeutics PTCT:US $ 155.89M 17.29M
Regeneron Pharmaceuticals REGN:US $ 2560.1M 0.1M
Sarepta Therapeutics SRPT:US $ 195.69M 16.3M
Supernus Pharmaceuticals SUPN:US $ 149.59M 15.02M
Vertex Pharmaceuticals VRTX:US $ 1934.4M 82.7M
YTE INCY:US $ 866.16M 170.14M